news-med.jpg

Evotec Enters into Research Collaboration with CRTD to Discover Novel Therapies for Retinal Diseases

COLLABORATION HIGHLIGHTS EVT INNOVATE’S BUSINESS MODEL TO ACCESS LEADING ACADEMIC EXPERTISE CRTD’S NEXT GENERATION STEM CELL MODELLING WILL ACCELERATE EVOTEC’S ABILITY TO DISCOVER NEW RETINAL DISEASE DRUGS Dresden and Hamburg, Germany, 13 December 2017: Evotec AG (Frankfurt Stock Exchange: EVT, ...

Topics: Corporate, Research collaboration, Retinal diseases Read More